Literature DB >> 24101509

Regulation of estrogen receptor α by histone methyltransferase SMYD2-mediated protein methylation.

Xi Zhang1, Kaori Tanaka, Jiusheng Yan, Jing Li, Danni Peng, Yuanyuan Jiang, Zhe Yang, Michelle C Barton, Hong Wen, Xiaobing Shi.   

Abstract

Estrogen receptor alpha (ERα) is a ligand-activated transcription factor. Upon estrogen stimulation, ERα recruits a number of coregulators, including both coactivators and corepressors, to the estrogen response elements, modulating gene activation or repression. Most coregulator complexes contain histone-modifying enzymes to control ERα target gene expression in an epigenetic manner. In addition to histones, these epigenetic modifiers can modify nonhistone proteins including ERα, thereby constituting another layer of transcriptional regulation. Here we show that SET and MYND domain containing 2 (SMYD2), a histone H3K4 and H3K36 methyltransferase, directly methylates ERα protein at lysine 266 (K266) both in vitro and in cells. In breast cancer MCF7 cells, SMYD2 attenuates the chromatin recruitment of ERα to prevent ERα target gene activation under an estrogen-depleted condition. Importantly, the SMYD2-mediated repression of ERα target gene expression is mediated by the methylation of ERα at K266 in the nucleus, but not the methylation of histone H3K4. Upon estrogen stimulation, ERα-K266 methylation is diminished, thereby enabling p300/cAMP response element-binding protein-binding protein to acetylate ERα at K266, which is known to promote ERα transactivation activity. Our study identifies a previously undescribed inhibitory methylation event on ERα. Our data suggest that the dynamic cross-talk between SMYD2-mediated ERα protein methylation and p300/cAMP response element-binding protein-binding protein-dependent ERα acetylation plays an important role in fine-tuning the functions of ERα at chromatin and the estrogen-induced gene expression profiles.

Entities:  

Keywords:  ERα hinge region; LSD1; lysine methylation

Mesh:

Substances:

Year:  2013        PMID: 24101509      PMCID: PMC3808627          DOI: 10.1073/pnas.1307959110

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  35 in total

Review 1.  Coactivator and corepressor complexes in nuclear receptor function.

Authors:  L Xu; C K Glass; M G Rosenfeld
Journal:  Curr Opin Genet Dev       Date:  1999-04       Impact factor: 5.578

2.  Direct acetylation of the estrogen receptor alpha hinge region by p300 regulates transactivation and hormone sensitivity.

Authors:  C Wang; M Fu; R H Angeletti; L Siconolfi-Baez; A T Reutens; C Albanese; M P Lisanti; B S Katzenellenbogen; S Kato; T Hopp; S A Fuqua; G N Lopez; P J Kushner; R G Pestell
Journal:  J Biol Chem       Date:  2001-03-09       Impact factor: 5.157

3.  Methylation of histone H4 at arginine 3 occurs in vivo and is mediated by the nuclear receptor coactivator PRMT1.

Authors:  B D Strahl; S D Briggs; C J Brame; J A Caldwell; S S Koh; H Ma; R G Cook; J Shabanowitz; D F Hunt; M R Stallcup; C D Allis
Journal:  Curr Biol       Date:  2001-06-26       Impact factor: 10.834

Review 4.  Chaperone functions of the heat shock proteins associated with steroid receptors.

Authors:  W B Pratt; M J Welsh
Journal:  Semin Cell Biol       Date:  1994-04

Review 5.  Molecular mechanisms of action of steroid/thyroid receptor superfamily members.

Authors:  M J Tsai; B W O'Malley
Journal:  Annu Rev Biochem       Date:  1994       Impact factor: 23.643

6.  Synergistic enhancement of nuclear receptor function by p160 coactivators and two coactivators with protein methyltransferase activities.

Authors:  S S Koh; D Chen; Y H Lee; M R Stallcup
Journal:  J Biol Chem       Date:  2001-01-12       Impact factor: 5.157

7.  Methylation of histone H4 at arginine 3 facilitating transcriptional activation by nuclear hormone receptor.

Authors:  H Wang; Z Q Huang; L Xia; Q Feng; H Erdjument-Bromage; B D Strahl; S D Briggs; C D Allis; J Wong; P Tempst; Y Zhang
Journal:  Science       Date:  2001-05-31       Impact factor: 47.728

8.  Tamoxifen resistance by a conformational arrest of the estrogen receptor alpha after PKA activation in breast cancer.

Authors:  Rob Michalides; Alexander Griekspoor; Astrid Balkenende; Desiree Verwoerd; Lennert Janssen; Kees Jalink; Arno Floore; Arno Velds; Laura van't Veer; Jacques Neefjes
Journal:  Cancer Cell       Date:  2004-06       Impact factor: 31.743

9.  Requirement of histone methyltransferase SMYD3 for estrogen receptor-mediated transcription.

Authors:  Hyunjung Kim; Kyu Heo; Jeong Hoon Kim; Kyunghwan Kim; Jongkyu Choi; Woojin An
Journal:  J Biol Chem       Date:  2009-06-09       Impact factor: 5.157

10.  Low phosphorylation of estrogen receptor alpha (ERalpha) serine 118 and high phosphorylation of ERalpha serine 167 improve survival in ER-positive breast cancer.

Authors:  Hiroko Yamashita; Mariko Nishio; Tatsuya Toyama; Hiroshi Sugiura; Naoto Kondo; Shunzo Kobayashi; Yoshitaka Fujii; Hirotaka Iwase
Journal:  Endocr Relat Cancer       Date:  2008-06-12       Impact factor: 5.678

View more
  66 in total

1.  Changes in Gene Expression and Estrogen Receptor Cistrome in Mouse Liver Upon Acute E2 Treatment.

Authors:  Gaëlle Palierne; Aurélie Fabre; Romain Solinhac; Christine Le Péron; Stéphane Avner; Françoise Lenfant; Coralie Fontaine; Gilles Salbert; Gilles Flouriot; Jean-François Arnal; Raphaël Métivier
Journal:  Mol Endocrinol       Date:  2016-05-10

Review 2.  Perimenopause as a neurological transition state.

Authors:  Roberta D Brinton; Jia Yao; Fei Yin; Wendy J Mack; Enrique Cadenas
Journal:  Nat Rev Endocrinol       Date:  2015-05-26       Impact factor: 43.330

Review 3.  KDM1 class flavin-dependent protein lysine demethylases.

Authors:  Jonathan M Burg; Jennifer E Link; Brittany S Morgan; Frederick J Heller; Amanda E Hargrove; Dewey G McCafferty
Journal:  Biopolymers       Date:  2015-07       Impact factor: 2.505

Review 4.  Inhibitors of Protein Methyltransferases and Demethylases.

Authors:  H Ümit Kaniskan; Michael L Martini; Jian Jin
Journal:  Chem Rev       Date:  2017-03-24       Impact factor: 60.622

5.  Structural Basis for Substrate Preference of SMYD3, a SET Domain-containing Protein Lysine Methyltransferase.

Authors:  Weiqi Fu; Nan Liu; Qi Qiao; Mingzhu Wang; Jinrong Min; Bing Zhu; Rui-Ming Xu; Na Yang
Journal:  J Biol Chem       Date:  2016-02-29       Impact factor: 5.157

6.  A motif in HSP90 and P23 that links molecular chaperones to efficient estrogen receptor α methylation by the lysine methyltransferase SMYD2.

Authors:  Wolfgang M J Obermann
Journal:  J Biol Chem       Date:  2018-09-06       Impact factor: 5.157

Review 7.  Nuclear receptors and epigenetic regulation: opportunities for nutritional targeting and disease prevention.

Authors:  Donato F Romagnolo; Janos Zempleni; Ornella I Selmin
Journal:  Adv Nutr       Date:  2014-07-14       Impact factor: 8.701

Review 8.  H3K36 methyltransferases as cancer drug targets: rationale and perspectives for inhibitor development.

Authors:  David S Rogawski; Jolanta Grembecka; Tomasz Cierpicki
Journal:  Future Med Chem       Date:  2016-08-22       Impact factor: 3.808

Review 9.  Nonhistone Lysine Methylation in the Regulation of Cancer Pathways.

Authors:  Scott M Carlson; Or Gozani
Journal:  Cold Spring Harb Perspect Med       Date:  2016-11-01       Impact factor: 6.915

Review 10.  Sex, epilepsy, and epigenetics.

Authors:  Irfan A Qureshi; Mark F Mehler
Journal:  Neurobiol Dis       Date:  2014-07-04       Impact factor: 5.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.